The table below shows CG Oncology, Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
Revenue
$4.04M
$1.14M
$204.00K
Cost of revenue
-
-
-
Gross profit
-
-
-
R&D
$116.64M
$82.10M
$45.75M
SG&A
$73.53M
$33.70M
$9.90M
Operating income
-$190.77M
-$114.67M
-$55.45M
Income tax
-$270.00K
$1.00K
$1.00K
Net income
CGON annual revenue (10-K history)
CG Oncology, Inc. reported annual revenue of $4.04M for fiscal year 2025. That is up 254.7% from $1.14M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.